天津中医药2018，Vol.35Issue(1)：20-24,5.DOI:10.11656/j.issn.1672-1519.2018.01.06
中成药治疗冠状动脉血运重建术后疗效与安全性的系统评价
A systematic review of the efficacy and safety of Chinese patent medicine in the treatment of coronary revascularization
摘要
Abstract
[Objective] Evaluation of the clinical efficacy and safety of Western medicine in the treatment of postoperative of coronary revascularization with oral proprietary Chinese patent medicine and conventional Western medicine alone. [Methods] A randomized controlled trials were conducted to evaluate the efficacy of Western medicine in the treatment of postoperative of coronary revascularization with oral proprietary Chinese patent medicine and conventional Western medicine. According to the related methods of Cochrane collaboration network, the quality of the literature and the effective correlation Data were Meta analysis. [Results] A total of 15 studies were included, including 1350 patients. The results showed that Western medicine combined with oral Chinese medicine can not only improve the coronary revascularization in patients with postoperative traditional Chinese medicine syndrome, clinical total curative effect, angina pectoris and ECG curative effect, reduce the restenosis rate, increase cardiac output, but also can inhibit the expression of inflammatory factor. [Conclusion] Compare with Western medicine, Western medicine combine with oral proprietary Chinese patent medicine can be used to treat postoperative of coronary revascularization in patients with acute mycocardial infarction.关键词
中成药/冠状动脉血运重建术后/系统评价/Meta分析Key words
Chinese patent medicine/postoperative of coronary revascularization/system evaluation/Meta analysis分类
医药卫生引用本文复制引用
唐耿义,唐娥,赵桂峰..中成药治疗冠状动脉血运重建术后疗效与安全性的系统评价[J].天津中医药,2018,35(1):20-24,5.基金项目
天津市卫计委中医中西医结合课题(2015086). （2015086）
